Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Cohen

Showing results (871-880 of 1,023) with videos related to

Pageof 103
Sort By:
American Journal of Industrial Medicine|June 22, 2013
The respiratory pyramid: From symptoms to disease in World Trade Center exposed firefightersJustin K Niles, Mayris P Webber, Hillel W Cohen, et al.
International Journal of Cardiology|July 27, 2015
Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitisM R Hazebroek, M J Kemna, S Schalla, et al.
Cancer|May 22, 2014
Treatment of advanced thyroid cancer with axitinib: Phase 2 study with pharmacokinetic/pharmacodynamic and quality-of-life assessmentsLaura D Locati, Lisa Licitra, Laura Agate, et al.
Cancer|June 20, 2020
Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancerGlenn J Hanna, Jeffrey P Guenette, Nicole G Chau, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
The spontaneous neoantigen-specific CD4<sup>+</sup> T cell response to a growing tumor is functionally and phenotypically diverseRyan Q Griswold, Spencer E Brightman, Karla Soria Zavala, et al.
Plos Pathogens|May 28, 2021
PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infectionSean C Murphy, Gregory A Deye, B Kim Lee Sim, et al.
Clinical Pharmacology and Therapeutics|March 19, 2014
Sorafenib dose escalation is not uniformly associated with blood pressure elevations in normotensive patients with advanced malignanciesS Karovic, Y Wen, T G Karrison, et al.
AIDS (London, England)|June 5, 1999
Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study)J W Cohen Stuart, R Schuurman, D M Burger, et al.
Cell Cycle (Georgetown, Tex.)|November 15, 2006
Cell cycle regulatory proteins in the liver in murine Trypanosoma cruzi infectionBoumediene Bouzahzah, Fnu Nagajyothi, Mahalia S Desruisseaux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 11, 2008
Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II studyEzra E W Cohen, Lee S Rosen, Everett E Vokes, et al.
Pageof 103

Showing results (871-880 of 1,023) with videos related to

Sort By:
Pageof 103
American Journal of Industrial Medicine|June 22, 2013
The respiratory pyramid: From symptoms to disease in World Trade Center exposed firefightersJustin K Niles, Mayris P Webber, Hillel W Cohen, et al.
International Journal of Cardiology|July 27, 2015
Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitisM R Hazebroek, M J Kemna, S Schalla, et al.
Cancer|May 22, 2014
Treatment of advanced thyroid cancer with axitinib: Phase 2 study with pharmacokinetic/pharmacodynamic and quality-of-life assessmentsLaura D Locati, Lisa Licitra, Laura Agate, et al.
Cancer|June 20, 2020
Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancerGlenn J Hanna, Jeffrey P Guenette, Nicole G Chau, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
The spontaneous neoantigen-specific CD4<sup>+</sup> T cell response to a growing tumor is functionally and phenotypically diverseRyan Q Griswold, Spencer E Brightman, Karla Soria Zavala, et al.
Plos Pathogens|May 28, 2021
PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infectionSean C Murphy, Gregory A Deye, B Kim Lee Sim, et al.
Clinical Pharmacology and Therapeutics|March 19, 2014
Sorafenib dose escalation is not uniformly associated with blood pressure elevations in normotensive patients with advanced malignanciesS Karovic, Y Wen, T G Karrison, et al.
AIDS (London, England)|June 5, 1999
Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study)J W Cohen Stuart, R Schuurman, D M Burger, et al.
Cell Cycle (Georgetown, Tex.)|November 15, 2006
Cell cycle regulatory proteins in the liver in murine Trypanosoma cruzi infectionBoumediene Bouzahzah, Fnu Nagajyothi, Mahalia S Desruisseaux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 11, 2008
Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II studyEzra E W Cohen, Lee S Rosen, Everett E Vokes, et al.
Pageof 103